Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenue	$ 1,002	$ 1,602	$ 2,659	$ 3,871
Cost of revenues	193	300	438	600
Gross profit	809	1,302	2,221	3,271
Sales and marketing expenses	22	16	77	124
General and administrative expenses	493	723	1,838	2,245
Research and development costs	80	123	402	507
Other operating income	0	0	0	(227)
Operating income (loss)	214	440	(96)	622
Gain (loss) from change in fair value of hybrid financial instruments	(1,369)	4,495	(2,542)	28,549
Gain (loss) from change in fair value of derivative liability - warrants	38	90	618	3,514
Gain (loss) from change in fair value of derivative liability - Series C and D preferred stock and debentures	29	31	273	2,029
Gain on extinguishment of Debt	0	53	4,247	53
Interest income	0	0	0	16
Net income/(loss)	(1,088)	5,109	2,500	34,783
Deemed dividends on convertible preferred stock	0	0	0	(16)
Deemed dividends on convertible debentures	0	(45)	0	(726)
Net income (loss) available to common shareholders	(1,088)	5,064	2,500	34,041
Comprehensive income (loss):
Net income (loss)	(1,088)	5,109	2,500	34,783
Foreign currency adjustment	0	0	0	133
Comprehensive income (loss):	$ (1,088)	$ 5,109	$ 2,500	$ 34,916
Net income (loss) per common share, basic and diluted:
Basic (in dollars per share)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Fully diluted (in dollars per share)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted average number of common shares:
Basic (in shares)	1,357,349,653	4,984,827,279	810,443,147	3,823,483,604
Fully diluted (in shares)	1,395,781,353	5,023,258,979	848,874,847	3,861,915,304